Aleo BME's Medical Product Pipeline

Products for both the consumer market and the $6B bioadhesive market are in development

Aleo BME has developed a pipeline of 510K and premarket approval programs that are at various stages of development. The pipeline represents the lead candidates from Aleo's library of polymeric compounds that have been qualified using rigorous, iterative assays deemed critical to medical device and cosmetic applications. The most advanced development programs are targeting commercially attractive opportunities in the areas of tissue health and regeneration, notably adhesives and sealants.  Programs for medical device coatings and agricultural performance enhancement are in early stage development as well and are seeking partnerships.